Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today

The company had attracted much interest due to its heavy use of artificial intelligence, but its latest fundamentals disappointed many.

Related Keywords

Chris Gibson ,Recursion Pharmaceuticals ,Motley Fool Stock Advisor ,Stock Advisor ,Recursion ,